Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
280.2 SEK | 0.00% | +1.16% | +4.94% |
May. 24 | Sobi North America Gets FDA Fast Track Designation for Rheumatic Disease Complication Treatment | DJ |
May. 14 | Swedish Orphan Biovitrum AB Elects Zlatko Rihter as New Board Member | CI |
Sales 2024 * | 24.52B 2.3B | Sales 2025 * | 27.15B 2.55B | Capitalization | 95.23B 8.93B |
---|---|---|---|---|---|
Net income 2024 * | 3.35B 314M | Net income 2025 * | 4.91B 461M | EV / Sales 2024 * | 4.48 x |
Net Debt 2024 * | 14.54B 1.36B | Net Debt 2025 * | 9.22B 864M | EV / Sales 2025 * | 3.85 x |
P/E ratio 2024 * |
28.6
x | P/E ratio 2025 * |
19.6
x | Employees | 1,752 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 50.87% |
Latest transcript on Swedish Orphan Biovitrum AB
1 week | +1.16% | ||
Current month | -1.82% | ||
1 month | +5.18% | ||
3 months | +6.78% | ||
6 months | +10.66% | ||
Current year | +4.94% |
Managers | Title | Age | Since |
---|---|---|---|
Guido Oelkers
CEO | Chief Executive Officer | 59 | 17-05-21 |
Henrik Stenqvist
DFI | Director of Finance/CFO | 57 | 18-07-19 |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 68 | 20-12-31 | |
Annette Clancy
CHM | Chairman | 70 | 14-05-07 |
Staffan Schüberg
BRD | Director/Board Member | 55 | 19-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.15% | 232 M€ | +14.08% | ||
0.90% | 5 M€ | +16.14% | ||
0.69% | 142 M€ | +13.30% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 280.2 | 0.00% | 143,693 |
24-05-23 | 280.2 | +0.65% | 125,549 |
24-05-22 | 278.4 | 0.00% | 417,287 |
24-05-21 | 278.4 | -0.85% | 232,145 |
24-05-20 | 280.8 | +1.37% | 360,977 |
Delayed Quote Nasdaq Stockholm, May 24, 2024 at 11:29 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.94% | 8.94B | |
-2.00% | 90.02B | |
-1.18% | 39.15B | |
-15.83% | 31.71B | |
+62.86% | 26.47B | |
-21.68% | 14.34B | |
-8.73% | 12.89B | |
-15.05% | 11.18B | |
-45.69% | 10.97B | |
+96.04% | 7.49B |
- Stock Market
- Equities
- SOBI Stock